Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice
South Korea
10-2012-7024527
Filed on 2011-02-27
10-2012-7024527
Filed on 2011-02-27
Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice
China
201180012191.8
Filed on 2011-02-27
201180012191.8
Filed on 2011-02-27
Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice
Canada
2790869
Filed on 2011-02-27
2790869
Filed on 2011-02-27
A3AR AGONISTS FOR THE TREATMENT OF UVEITIS
European Patent
11710888.6
Filed on 2011-02-27
11710888.6
Filed on 2011-02-27
Effect Of CF101 Reverses The Development Of Experimental Autoimmune Uveoretintis In Mice
Mexico
MX/0/2012/0/0006
Filed on 2011-02-27
MX/0/2012/0/0006
Filed on 2011-02-27
Nitisinone For Treatment Of Oculocutaneious/Ocular Albinism And For Increasing Pigmentation
US Patent 8,822,540
Filed on 2012-09-06
Filed on 2012-09-06
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
European Patent
11706137.4
Filed on 2011-02-25
11706137.4
Filed on 2011-02-25
Nitisinone For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
Canada
2791245
Filed on 2011-02-25
2791245
Filed on 2011-02-25
Nitisinone (NTBC) For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation
Australia
2011220475
Filed on 2011-02-25
2011220475
Filed on 2011-02-25
METHODS OF DIAGNOSING AND TREATING AGE-RELATED MACULAR DEGENERATION
Patent Cooperation Treaty
PCT/US12/022511
Filed on 2012-01-25
PCT/US12/022511
Filed on 2012-01-25